(XAIR) – StreetInsider.com Reports
-
Beyond Air, Inc. (XAIR) Prices 9.64M Share Offering at $1.66/sh
-
Beyond Air, Inc. (XAIR) Tops Q3 EPS by 4c
-
Beyond Cancer (XAIR) Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors
-
Beyond Air, Inc. (XAIR) sees a couple large insider buys
-
Beyond Air (XAIR) PT Lowered to $10 at Truist Securities
-
Beyond Air, Inc. (XAIR) Misses Q2 EPS by 4c
-
Beyond Air, Inc. (XAIR) Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors
-
Beyond Air (XAIR) Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival i
-
Beyond Air (XAIR) Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide in Combination with Checkpoint Inhibitor Therapy
-
Beyond Air, Inc. (XAIR) Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder
-
Beyond Air, Inc. (XAIR) and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region
-
Beyond Air, Inc. (XAIR) director buys nearly $700k in stock
-
Beyond Air, Inc. (XAIR) Announces 626K Share Offering by Selling Stockholders
-
Beyond Air (XAIR) PT Lowered to $13 at BTIG
-
Beyond Air, Inc. (XAIR) Tops Q1 EPS by 2c
-
Piper Sandler Starts Beyond Air (XAIR) at Overweight, 'the most appealing value creation opportunities for shareholders'
-
Beyond Air (XAIR) PT Lowered to $12 at Roth/MKM
-
Beyond Air (XAIR) PT Lowered to $10 at Oppenheimer
-
Beyond Air, Inc. (XAIR) Secures up to $40M Debt Financing
-
BTIG Starts Beyond Air (XAIR) at Buy
-
Beyond Air, Inc. (XAIR) Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy
-
Beyond Air (XAIR) Appoints Jeff Myers as Chief Medical Officer
-
Beyond Air (XAIR) PT Lowered to $18 at Truist Securities
-
Beyond Air, Inc. (XAIR) Appoints Gavin Choy as COO
-
Beyond Air, Inc. (XAIR) Publishes Pre-Clinical Data in Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Concentration Nitric Oxide Induced a Systemic Response tha
-
Beyond Air, Inc. (XAIR) Presents Promising New In Vivo Data Showing Ultra-High Concentration Nitric Oxide Therapy (UNO) in Combination with Anti-PD-1
-
Beyond Air (XAIR) Reports Positive Data for Inhaled Nitric Oxide (NO) to Treat COVID-19 with LungFit PRO
-
Beyond Air (XAIR) Announces Positive Data from At-Home Pilot Study in Patients with Refractory NTM Lung Infection Treated with using the LungFit GO at the CHEST Annual Meeting 2022
-
Beyond Air (XAIR) PT Raised to $15 at Roth Capital
-
Pre-Open Stock Movers 06/29: Bed Bath & Beyond Sinks Following Results/CEO Change; Pinterest Gains on CEO Change (more...)
-
Beyond Air (XAIR) Thoughts on FDA Approval - Oppenheimer
-
Beyond Air (XAIR) PT Raised to $20 at Truist Securities
-
Beyond Air (XAIR) PT Raised to $23 at Ladenburg Thalmann
-
After-Hours Stock Movers 06/28: Pinterest Gains as CEO Steps Down; AeroVironment Falls on Earnings Miss (more...)
-
Beyond Air, Inc. (XAIR) Climbs 38% After FDA Approval of LungFit to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure
-
Beyond Air, Inc. (XAIR) Announces FDA Approval of LungFit to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure
-
Beyond Air's (XAIR) Beyond Cancer Appoints Jedidiah Monson as Chief Medical Officer
-
Beyond Air, Inc. (XAIR) Reports Positive Study Update from the At-Home LungFit GO Pilot Study
-
Beyond Air (XAIR) Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis
-
Beyond Air, Inc. (XAIR) Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022
-
Pre-Open Stock Movers 03/22: (GEVO) (RAIL) (BABA) Higher; (STAB) (AGTC) (OKTA) Lower
-
After-Hours Stock Movers 03/21: (HRT) (XAIR) (NKE) Higher; (STAB) (AGTC) (TME) Lower
-
Beyond Air, Inc. (XAIR) Director Carey Bought 20K Shares
-
Beyond Air, Inc. (XAIR) Files $200M Mixed Shelf
-
Beyond Air, Inc. (XAIR) Director Carey Buys 10K Shares
-
Beyond Air, Inc. (XAIR) CEO Buys 40K Shares
-
Beyond Air, Inc. (XAIR) Announces Delay in Approval Timeline for LungFit PH
-
Beyond Air, Inc. (XAIR) Announces Appointment of Dr. Andrew Colin to Chief Medical Officer
-
Beyond Air (XAIR) PT Raised to $16 at Truist Securities
-
Beyond Air, Inc. (XAIR) Separates Cancer Business into Beyond Cancer
Back to XAIR Stock Lookup